Armstrong, A. W., Jaleel, T., Merola, J. F., Gottlieb, A. B., Khattri, S., Helt, C. C., … de Vlam, K. (2024). Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb), 14(8), 2297. https://doi.org/10.1007/s13555-024-01221-0

Armstrong, April W., Tarannum Jaleel, Joseph F. Merola, Alice B. Gottlieb, Saakshi Khattri, Cameron C. Helt, William N. Malatestinic, Sarah E. Ross, Marcus E. Ngantcha, and Kurt de Vlam. “Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity.” Dermatol Ther (Heidelb) 14, no. 8 (August 2024): 2297. https://doi.org/10.1007/s13555-024-01221-0.

Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, et al. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 Aug;14(8):2297.

Armstrong, April W., et al. “Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity.” Dermatol Ther (Heidelb), vol. 14, no. 8, Aug. 2024, p. 2297. Pubmed, doi:10.1007/s13555-024-01221-0.

Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 Aug;14(8):2297.